GLP-1 analogues have shown significant promise in managing obesity and diabetes, but like any medication, they may have side effects and interact with other drugs
Thirst suppression is particularly problematic considering the drugs other side effects, such as vomiting and diarrhea, which cause dehydration, Daniels added
Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial Retatrutide, Eli Lillys next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight
Existing GLP-1 injection users For the millions of people already using GLP-1 injections, tablets raise a different question
Neither TRIUMPH-4 nor TRIUMPH-1 published detailed data about whether dysesthesia resolved during the trials, worsened over time, or persisted unchanged
GLP-1 peptides are medications that mimic the natural hormone GLP-1, which helps regulate blood sugar levels and appetite